Thomas R. Staab II, Senior Vice President and CFO at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 29,154 shares at $4.43 ($129K) on 2016-08-09, disclosed to the SEC on 2016-08-11.
Open-market sale of $129k BCRX by Senior Vice President and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.43 | 14,577 | $65K | 50.0% |
| 2 | $4.43 | 14,577 | $65K | 50.0% |
| Total | $4.43 avg | 29,154 | $129K | 100% |
| Filing → |
| BCRX | SELL | 2019-05-16 | $92K | — | Filing → |
| BCRX | SELL | 2019-05-13 | $224K | — | Filing → |
| BCRX | SELL | 2019-05-06 | $126K | — | Filing → |